Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.6B; returns 1 day -2.7%, 1 week -1.6%, 1 year +67.1%.

Krystal Biotech Inc. is a fully integrated, commercial-stage global biotechnology company focused on the discovery, development, and commercialization of genetic medicines for diseases with high unmet medical needs.

Groups KRYS belongs to

• Biotechnology
• Gene Therapy
• Rare Diseases
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Biopharmaceutical
• Unmet Medical Needs
• Cystic Fibrosis Therapies
• Dermatology

KRYS financial model: income statement, cash flow and balance sheet